Published : Mar-2018
No. of Pages : 44
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Non Malignant pain to Central Nervous System Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
Clinical Trials by Trial Status 16
Clinical Trials by End Point Status 17
Clinical Trials by Sponsor Type 18
Prominent Sponsors 19
Top Companies Participating in Non Malignant pain Therapeutics Clinical Trials 20
Prominent Drugs 21
Clinical Trial Profile Snapshots 22
Appendix 42
Abbreviations 42
Definitions 42
Research Methodology 43
Secondary Research 43
About GlobalData 44
Contact Us 44
Source 44
List of Tables
Non Malignant pain Therapeutics, Global, Clinical Trials by Region, 2018* 6
Non Malignant pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Non Malignant pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Non Malignant pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 9
Non Malignant pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 10
Non Malignant pain Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
Proportion of Non Malignant pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 12
Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 13
Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 14
Non Malignant pain Therapeutics, Global, Clinical Trials by Phase, 2018* 15
Non Malignant pain Therapeutics, Global, Clinical Trials by Trial Status, 2018* 16
Non Malignant pain Therapeutics Clinical Trials, Global, by End Point Status, 2018* 17
Non Malignant pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 18
Non Malignant pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 19
Non Malignant pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 20
Non Malignant pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 21
List of Figures
Non Malignant pain Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Non Malignant pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Non Malignant pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Non Malignant pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 9
Non Malignant pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 10
Non Malignant pain Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 11
Proportion of Non Malignant pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 12
Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 13
Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 14
Non Malignant pain Therapeutics, Global, Clinical Trials by Phase (%), 2018* 15
Non Malignant pain Therapeutics, Global, Clinical Trials by Trial Status, 2018* 16
Non Malignant pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 18
Non Malignant pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 19
Non Malignant pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 20
Non Malignant pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 21
GlobalData Methodology 43
